(Q39843293)

15 September 2017

The English national screening programme for sight-threatening diabetic retinopathy (English)

1 reference

15 September 2017

P H Scanlon

1

1 reference

15 September 2017

1 January 2008

1 reference

Journal of Medical Screening

15 September 2017

1 reference

15 September 2017

15

1 reference

15 September 2017

1

1 reference

15 September 2017

1-4

1 reference

Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment

15 September 2017

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Effectiveness of screening and monitoring tests for diabetic retinopathy--a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Practical community screening for diabetic retinopathy using the mobile retinal camera: report of a 12 centre study. British Diabetic Association Mobile Retinal Screening Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Preservation of sight in diabetes: developing a national risk reduction programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Leading causes of certification for blindness and partial sight in England & Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Visual impairment and blindness in Europe and their prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

The use of digital cameras in a mobile retinal screening environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

High-resolution stereoscopic digital fundus photography versus contact lens biomicroscopy for the detection of clinically significant macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Cost-effectiveness of the screening and treatment of diabetic retinopathy. What are the costs of underutilization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Cost effectiveness analysis of screening for sight threatening diabetic eye disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

A pilot quality assurance scheme for diabetic retinopathy risk reduction programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

The changing epidemiology of diabetic microangiopathy in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

New blindness in diabetes reduced by more than one-third in Stockholm County.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Effectiveness of screening in preventing blindness due to diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Screening and prevention of diabetic blindness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Screening compliance and visual outcome in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

Incidence of blindness due to diabetic eye disease in Fife 1990-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FJMS.2008.008015

21 January 2018

Identifiers

DOI

10.1258/JMS.2008.008015

1 reference

15 September 2017

1 reference

PubMed ID

18416946